Treatment of proliferative diabetic retinopathy with anti-VEGF agents

Acta Ophthalmologica

Volumn 89, Issue 5, 2011, Pages 405-411

  Salam, Aysha ^a   Mathew, Raeba ^a   Sivaprasad, Sobha ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

anti VEGF; bevacizumab; pegaptanib sodium; proliferative diabetic retinopathy; ranibizumab

Indexed keywords

ANTIGLAUCOMA AGENT; BEVACIZUMAB; PEGAPTANIB; RANIBIZUMAB; STEROID; VASCULOTROPIN ANTIBODY;

ACUTE DISEASE; ADJUVANT THERAPY; CARCINOGENICITY; CARDIOVASCULAR DISEASE; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INDICATION; DRUG MEGADOSE; DRUG SAFETY; ENDOPHTHALMITIS; GLAUCOMA; GLAUCOMA SURGERY; HUMAN; HYPERTENSION; INFERTILITY; INTRACTABLE GLAUCOMA; INTRAOCULAR PRESSURE; LASER COAGULATION; LENS DISEASE; NEOVASCULAR GLAUCOMA; OPERATION DURATION; OUTCOME ASSESSMENT; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; RETINA DETACHMENT; RETINA HEMORRHAGE; RETINA MACULA EDEMA; RETINA MACULA HOLE; RETINA NEOVASCULARIZATION; RETINA TEAR; REVIEW; RISK FACTOR; SIDE EFFECT; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TERATOGENICITY; TRACTIONAL RETINA DETACHMENT; VISUAL ACUITY; VISUAL DISORDER; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT; VITREOUS HEMORRHAGE;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; APTAMERS, NUCLEOTIDE; DIABETIC RETINOPATHY; HUMANS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79959352011     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2010.02079.x     Document Type: Review

References (89)

1. Abdallah W, &, Fawzi A, (2009): Anti-VEGF therapy in proliferative diabetic retinopathy. Int Ophthalmol Clin 49: 95-97.
2. Adamis AP, Miller JW, Bernal MT, D' Amico DJ, Folkman J, Yeo TK, &, Yeo KT, (1994): Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118: 445-450. (Pubitemid 24307211)
3. Adamis AP, Altaweel M, Bressler NM, et al., (2006): Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals. Ophthalmology 113: 23-28. (Pubitemid 43021723)
4. Ahmadieh H, Shoeibi N, Entezari M, &, Monshizadeh R, (2009): Intravitreal IVB for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial. Ophthalmology 116: 1943-1948.
5. Arevalo JF, &, Garcia-Amaris RA, (2009): Intravitreal IVB for diabetic retinopathy. Curr Diabetes Rev 5: 39-46.
6. Arevalo JF, Maia M, Flynn HW Jr, et al., (2008): Tractional retinal detachment following intravitreal IVB (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol 92: 213-216. (Pubitemid 351224097)
7. Arevalo JF, Wu L, Sanchez JG, Maia M, Saravia MJ, Fernandez CF, &, Evans T, (2009): Intravitreal IVB (Avastin) for proliferative diabetic retinopathy: 6-months follow-up. Eye (Lond) 23: 117-123.
8. Arimura N, Otsuka H, Yamakiri K, et al., (2009): Vitreous mediators after intravitreal IVB or triamcinolone acetonide in eyes with proliferative diabetic retinopathy. Ophthalmology 116: 921-926.
9. Avery RL, (2006): Regression of retinal and iris neovascularization after intravitreal IVB (Avastin) treatment. Retina 26: 352-354. (Pubitemid 44318195)
10. Avery RL, Pearlman J, Pieramici DJ, et al., (2006): Intravitreal IVB (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 113: 1695 e1-1695 e15.
11. Bakri SJ, &, Kitzmann AS, (2007): Retinal pigment epithelial tear after intravitreal ranibizumab. Am J Ophthalmol 143: 505-507. (Pubitemid 46273349)
12. Batman C, &, Ozdamar Y, (2010): The relation between IVB injection and the formation of subretinal fibrosis in diabetic patients with panretinal photocoagulation. Ophthalmic Surg Lasers Imaging 41/2: 1542-8877.
13. Beutel J, Peters S, Luke M, et al., (2010): Bevacizumab as adjuvant for neovascular glaucoma. Acta Opthalmol 88: 103-109.
14. Brucker AJ, Qin H, Antoszyk AN, et al., (2009): Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings. Diabetic Retinopathy Clinical Research Network. Arch Ophthalmol 127: 132-140.
15. Chalam KV, Guphta SK, Grover S, et al., (2008): Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma. Eur J Ophthalmol 18: 255-262. (Pubitemid 351692186)
16. Chen E, &, Park CH, (2006): Use of intravitreal IVB as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy. Retina 26: 699-700. (Pubitemid 44620378)
17. Cho WB, Oh SB, Moon JW, &, Kim HC, (2009): Panretinal photocoagulation combined with intravitreal IVB in high-risk proliferative diabetic retinopathy. Retina 29: 516-522.
18. Costagliola C, Cipollone U, Rinaldi M, Corte MD, Semeraro F, &, Romano MR, (2008): Intravitreal IVB (Avastin) injection for neovascular glaucoma: a survey on 23 cases throughout 12-month follow-up. Br J Clin Pharmacol 66: 667-673.
19. De Ruggiero P, Di Lauro R, Di Lauro MT, &, Romano MR, (2010): Intravitreal IVB for surgical treatment of severe proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 248: 785-791.
20. Eid TM, Radwan A, el-Manawy W, &, el-Hawary I, (2009): Intravitreal IVB and aqueous shunting surgery for neovascular glaucoma: safety and efficacy. Can J Ophthalmol 44: 451-456.
21. El-Batarny AM, (2007): Intravitreal IVB treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathy. Clin Ophthalmol 1: 149-155.
22. Erdol H, Turk A, Akyol N, &, Imamoglu HI, (2010): The results of intravitreal IVB injections for persistent neovascularizations in proliferative diabetic retinopathy after photocoagulation therapy. Retina 30/4: 1539-2864.
23. Falavarjani KG, Modarres M, &, Nazari H, (2010): Therapeutic effect of IVB injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy. Eye 24/4: 717-719.
24. Flynn HW Jr, Chew EY, Simons BD, Barton FB, Remaley NA, &, Ferris FL 3rd, (1992): Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS report number 17. The Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 99: 1351-1357.
25. Forooghian F, Kertes PJ, Eng KT, Agron E, &, Chew EY, (2010): Alterations in the intraocular cytokine milieu after intravitreal bevacizumab. Invest Ophthalmol Vis Sci 51: 2388-2392.
26. Frenkel RE, Mani L, Toler AR, &, Frenkel MP, (2007): Intraocular pressure effects of pegaptanib (Macugen) injections in patients with and without glaucoma. Am J Ophthalmol 143: 1034-1035. (Pubitemid 46764645)
27. Friedlander SM, &, Welch RM, (2006): Vanishing disc neovascularization following intravitreal IVB (avastin) injection. Arch Ophthalmol 124: 1365. (Pubitemid 44379881)
28. Fulda E, Ariza E, Lopez A, &, Graue F, (2010): Intravitreal IVB and panretinal photocoagulation as combined treatment in proliferative diabetic retinopathy. Retina-Vitreus 18/1: 52-55.
29. Gandhi JS, Tan LT, Pearce I, &, Charles SJ, (2009): IVB (Avastin) as a surgical adjunct in diabetic vitrectomy for fibrovascular disease. Eye (Lond) 23: 742-743.
30. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, &, Guyer DR, (2004): Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351: 2805-2816. (Pubitemid 40051904)
31. Group TDRSR (1981): Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmology 88: 583-600.
32. Gungel H, Altan C, &, Oygar Baylancicek D, (2010): The anatomical and functional outcomes and intraoperative complications of 20 gauge vs 23 gauge pars plana vitrectomy combined with phacoemulsification following intravitreal IVB in diabetic tractional retinal detachment. Retina-Vitreus 18/2: 122-128.
33. Hattori T, Shimada H, Nakashizuka H, Mizutani Y, Mori R, &, Yuzawa M, (2010): Dose of intravitreal IVB (Avastin) used as preoperative adjunct therapy for proliferative diabetic retinopathy. Retina 30: 761-764.
34. Hornan D, Edmeades N, Krishnan R, Khan J, &, Lochhead J, (2010): Use of pegaptanib for recurrent and non-clearing vitreous haemorrhage in proliferative diabetic retinopathy. Eye 24: 1315-1319.
35. Huang YH, Yeh PT, Chen MS, Yang CH, &, Yang CM, (2009): Intravitreal IVB and panretinal photocoagulation for proliferative diabetic retinopathy associated with vitreous hemorrhage. Retina 29: 1134-1140.
36. Hussain G, Ghanekar Y, &, Kaur I, (2007): The future implications and indications of anti-vascular endothelial growth factor therapy in ophthalmic practice. Indian J Ophthalmol 55: 445-450.
37. Isaacs TW, &, Barry C, (2006): Rapid resolution of severe disc new vessels in proliferative diabetic retinopathy following a single intravitreal injection of IVB (Avastin). Clin Experiment Ophthalmol 34: 802-803. (Pubitemid 44650158)
38. Ishikawa K, Honda S, Tsukahara Y, &, Negi A, (2009): Preferable use of intravitreal IVB as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy. Eye (Lond) 23: 108-111.
39. Jalil A, Chaudhry NL, Gandhi JS, Odat TM, &, Yodaiken M, (2007a): Inadvertent injection of triamcinolone into the crystalline lens. Eye 21: 152-154. (Pubitemid 46061919)
40. Jalil A, Fenerty C, &, Charles S, (2007b): Intravitreal IVB (Avastin) causing acute glaucoma: an unreported complication. Eye 21: 1541.
41. Jardeleza MSR, &, Miller JW, (2009): Review of anti-VEGF therapy in proliferative diabetic retinopathy. Semin Ophthalmol 84: 87-92.
42. Jonas BJ, Libondi T, Baltz S, &, Vossmerbaeumer U, (2008): Intravitreal bevacizumab for vitreous haemorrhage. Acta Ophthalmol 86: 585-586.
43. Jonas JB, Schmidbauer M, &, Rensch F, (2009): Progression of tractional retinal detachment following intravitreal bevacizumab. Acta Ophthalmol 87: 571-572.
44. Jorge R, Costa RA, Calucci D, Cintra LP, &, Scott IU, (2006): Intravitreal IVB (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study). Retina 26: 1006-1013. (Pubitemid 44973219)
45. Kempen JH, O' Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, Taylor HR, &, Hamman RF, (2004): The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 122: 552-563. (Pubitemid 38456292)
46. Kohno R, Hata Y, Mochizuki Y, et al., (2010): Histopathology of neovascular tissue from eyes with proliferative diabetic retinopathy after intravitreal IVB injection. Am J Ophthalmol 150: 223-229. e1.
47. Krishnan R, Goverdhan S, &, Lochhead J, (2009): Intravitreal pegaptanib in severe proliferative diabetic retinopathy leading to the progression of tractional retinal detachment. Eye 23: 1238-1239.
48. Krzystolik MG, Filippopoulos T, Ducharme JF, &, Loewenstein JI, (2006): Pegaptanib as an adjunctive treatment for complicated neovascular diabetic retinopathy. Arch Ophthalmol 124: 920-921. (Pubitemid 43877695)
49. Kubota T, Morita H, Tou N, Nitta N, Tawara A, Satoh H, &, Shimajiri S, (2010): Histology of fibrovascular membranes of proliferative diabetic retinopathy after intravitreal injection of bevacizumab. Retina 30/3: 468-472.
50. Kuiper E, Van Nieuwenhoven FA, de Smet MD, et al., (2008): The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy. PLoS ONE 3: e2675.
51. Kumar V, Ghosh B, Raina UK, &, Goel N, (2010): Efficacy and safety of one intravitreal injection of IVB in diabetic macular oedema. Acta Ophthalmol 88: e3.
52. Ladas ID, Karagiannis DA, Rouvas AA, Kotsolis AI, Liotsou A, &, Vergados I, (2009): Safety of repeat intravitreal injections of IVB versus ranibizumab: our experience after 2,000 injections. Retina 29: 313-318.
53. Lee CS, &, Koh HJ, (2008): Multiple retinal haemorrhages in diabetic retinopathy after adjunctive intravitreal IVB (Avastin) with pars plana vitrectomy. Acta Ophthalmol 86: 812-813.
54. Lee SJ, &, Koh HJ, (2009): Enlargement of the foveal avascular zone in diabetic retinopathy after adjunctive intravitreal IVB (avastin) with pars plana vitrectomy. J Ocul Pharmacol Ther 25: 173-174.
55. Lee J, Canny MD, Erkenez AD, Krilleke D, Ng YH, Shima DT, Pardi A, &, Jucker A, (2006): A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165. PNAS 102: 18902-18907. (Pubitemid 43049539)
56. Lim TH, Bae SH, Cho YJ, Lee JH, Kim HK, &, Sohn YH, (2009): Concentration of vascular endothelial growth factor after intracameral IVB injection in eyes with neovascular glaucoma. Korean J Ophthalmol 23: 188-192.
57. Liu L, Wu WC, &, Yeung L, et al., (2010): Ghost cell glaucoma after intravitreal IVB for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy. Ophthalmic Surg Lasers Imaging 41/1: 1542-8877.
58. Lo WR, Kim SJ, Aaberg TM Sr, Bergstrom C, Srivastava SK, Yan J, Martin DF, &, Hubbard GB 3rd, (2009): Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with IVB (avastin). Retina 29: 926-931.
59. Lucena D, Ribeiro JA, Costa RA, Barbosa JC, Scott IU, de Figueiredo- Pontes LL, &, Jorge R, (2009): Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal IVB (IBeTra study). Br J Ophthalmol 93: 688-691.
60. Mason JO, Yunker JJ, Cot RV, &, McGin JR, (2008): Intravitreal IVB (Avastin) prevention of panretinal photocoagulation induced complications in patients with severe proliferative diabetic retinopathy. Retina 28: 1319-1324.
61. Matsuyama K, Ogata N, Jo N, Shima C, Matsuoka M, &, Matsumura M, (2009): Levels of vascular endothelial growth factor and pigment epithelium-derived factor in eyes before and after intravitreal injection of bevacizumab. Jpn J Ophthalmol 53: 243-248.
62. Mendrinos E, Donati G, &, Pournaras CJ, (2009): Rapid and persistent regression of severe new vessels on the disc in proliferative diabetic retinopathy after a single intravitreal injection of pegaptanib. Acta Ophthalmol 87: 683-684.
63. Minnella AM, Savastano CM, Ziccardi L, Scupola A, Falsini B, &, Balestrazzi E, (2008): Intravitreal IVB (Avastin) in proliferative diabetic retinopathy. Acta Ophthalmol 86: 683-687.
64. Mirshahi A, Roohipoor R, Lashay A, Mohammadi SF, Abdoallahi A, &, Faghihi H, (2008): Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: a randomized double-masked clinical trial. Eur J Ophthalmol 18: 263-269. (Pubitemid 351692187)
65. Mitamura Y, Ogata K, Oshitari T, et al., (2008): Retinal detachment with macular hole following intravitreal IVB in patient with severe proliferative diabetic retinopathy. Br J Ophthalmol 92: 717-718. (Pubitemid 351684190)
66. Modarres M, Nazari H, Falavarjani KG, Naseripour M, Hashemi M, &, Parvaresh MM, (2009): Intravitreal injection of IVB before vitrectomy for proliferative diabetic retinopathy. Eur J Ophthalmol 19: 848-852.
67. Moradian S, Ahmadieh H, Malihi M, Soheilian M, Dehghan MH, &, Azarmina M, (2008): Intravitreal IVB in active progressive proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 246: 1699-1705.
68. Neubauer AS, Kook D, Haritoglou C, Priglinger SG, Kampik A, Ulbig MW, &, Ceklic L, (2007): IVB and retinal ischemia. Ophthalmology 114: 2096.
69. Ng YS, Krilleke D, &, Shima DT, (2006): VEGF function in vascular pathogenesis. Exp Cell Res 312: 527-537. (Pubitemid 43290330)
70. Oshima Y, Shima C, Wakabayashi T, Kusaka S, Shiraga F, Ohji M, &, Tano Y, (2009): Microincision vitrectomy surgery and intravitreal IVB as a surgical adjunct to treat diabetic traction retinal detachment. Ophthalmology 116: 927-938.
71. Pattwell DMST, Sheridan C, Heimann H, Gibran SK, Wong D, &, Hiscott P, (2010): Fibrous membranes in diabetic retinopathy and bevacizumab. Retina 30: 1012-1016.
72. Rizzo S, Genovesi-Ebert F, Di Bartolo E, Vento A, Miniaci S, &, Williams G, (2008): Injection of intravitreal IVB (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR). Graefes Arch Clin Exp Ophthalmol 246: 837-842.
73. Romano MR, Gibran SK, Marticorena J, Wong D, &, Heimann H, (2009): Can a preoperative IVB injection prevent recurrent postvitrectomy diabetic vitreous haemorrhage? Eye (Lond) 23: 1698-1701.
74. Rosenfeld PJ, Rich RM, &, Lalwani GA, (2006): Ranibizumab: phase III clinical trial results. Ophthalmol Clin North Am 19: 361-372. (Pubitemid 44279358)
75. Roth DB, King A, Weiss M, &, Klein D, (2009): Systemic adverse events after bevacizumab. Ophthalmology 116: 1226 e1.
76. Sawada O, Kawamura H, Kakinoki M, &, Ohji M, (2008): Vascular endothelial growth factor in fellow eyes of eyes injected with intravitreal bevacizumab. Graefes Arch Clin Exp Ophthalmol 246: 1379-1381.
77. Schmidinger G, Maar N, Bolz M, Scholda C, &, Schmidt-Erfurth U, (2009): Repeated intravitreal IVB (Avastin(R)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation. Acta Ophthalmol [Epub ahead of print].
78. Shih CW, Yang CM, Chen MS, &, Wang TJ, (2008): Intravitreal injection of IVB and gas for diabetic premacular hemorrhage with active fibrovascular proliferation. Graefes Arch Clin Exp Ophthalmol 246: 1547-1551.
79. Shima C, Sakaguchi H, Gomi F, et al., (2008): Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol 86: 372-376.
80. Shin YW, Lee YJ, Lee BR, &, Cho HY, (2009): Effects of an intravitreal IVB injection combined with panretinal photocoagulation on high-risk proliferative diabetic retinopathy. Korean J Ophthalmol 23: 266-272.
81. Spaide RF, &, Fisher YL, (2006): Intravitreal IVB (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 26: 275-278. (Pubitemid 44318179)
82. Thew M, (2009): Rapid resolution of severe retinal neovascularisation in proliferative diabetic retinopathy following adjunctive intravitreal IVB (Avastin). Clin Exp Optom 92: 34-37.
83. Tonello M, Costa RA, Almeida FP, Barbosa JC, Scott IU, &, Jorge R, (2008): Panretinal photocoagulation versus PRP plus intravitreal IVB for high-risk proliferative diabetic retinopathy (IBeHi study). Acta Ophthalmol 86: 385-389.
84. Torres-Soriano ME, Reyna-Castelán E, Hernández-Rojas M, et al., (2009): Tractional Retinal Detachment after Intravitreal injection of IVB in Proliferative Diabetic Retinopathy. Retin Cases Brief Rep 3: 70-73.
85. Tranos P, Gemenetzi M, Papandroudis A, Chrisafis C, &, Papadakos D, (2008): Progression of diabetic tractional retinal detachment following single injection of intravitreal Avastin. Eye 22: 862. (Pubitemid 351850529)
86. Wu L, Martinez-Castellanos MA, Quiroz-Mercado H, et al., (2008): Twelve-month safety of intravitreal injections of IVB (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol 246: 81-87. (Pubitemid 350167096)
87. Yang CM, Yeh PT, Yang CH, &, Chen MS, (2008): IVB pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy. Am J Ophthalmol 146: 211-217.
88. Yeh PT, Yang CM, Lin YC, Chen MS, &, Yang CH, (2009): IVB pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy. Retina 29: 768-774.
89. Yeoh J, Williams C, Allen P, et al., (2008): Avastin as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series. Clin Experiment Ophthalmol 36: 449-454.